ARYL-N-ARYL DERIVATIVES FOR TREATING RNA VIRAL INFECTION Russian patent published in 2024 - IPC C07D233/24 C07D401/12 A61K31/4168 A61K31/4439 A61P31/14 

FIELD: chemistry.

SUBSTANCE: group of inventions relates to a compound of formula (I):

(I),

also relates to compounds (1) - (181) or any pharmaceutically acceptable salts thereof, also relates to use of a compound of formula (I) or any of its pharmaceutically acceptable salts, or any of compounds (1) - (181), or any of its pharmaceutically acceptable salts for treating and/or preventing RNA virus infection caused by respiratory syncytial virus (RSV), also relates to a pharmaceutical composition for treating and/or preventing RNA virus infection caused by respiratory syncytial virus (RSV), containing a therapeutically effective amount of at least one of the compounds of formula (I), or any of its pharmaceutically acceptable salts, and any of compounds (1) - (181), or any of its pharmaceutically acceptable salts, as well as at least one pharmaceutically acceptable excipient, also relates to methods of synthesis for producing novel compounds of formula (I).

EFFECT: group of inventions provides the development of new compounds for treating or preventing RSV of a viral infection or a virus-related condition.

12 cl, 3 tbl, 14 ex